122 related articles for article (PubMed ID: 27538802)
1. Pathologic Risk Factors for Metastatic Disease in Postpubertal Patients With Clinical Stage I Testicular Stromal Tumors.
Rove KO; Maroni PD; Cost CR; Fairclough DL; Giannarini G; Harris AK; Schultz KA; Cost NG
Urology; 2016 Nov; 97():138-144. PubMed ID: 27538802
[TBL] [Abstract][Full Text] [Related]
2. Pathologic Risk Factors in Pediatric and Adolescent Patients With Clinical Stage I Testicular Stromal Tumors.
Rove KO; Maroni PD; Cost CR; Fairclough DL; Giannarini G; Harris AK; Schultz KA; Cost NG
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e441-6. PubMed ID: 26479987
[TBL] [Abstract][Full Text] [Related]
3. Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal Tumors.
Calaway AC; Tachibana I; Masterson TA; Foster RS; Einhorn LH; Cary C
Urology; 2019 May; 127():74-79. PubMed ID: 30807775
[TBL] [Abstract][Full Text] [Related]
4. Sex cord stromal testicular tumors: a clinical series--uniformly stage I disease.
Featherstone JM; Fernando HS; Theaker JM; Simmonds PD; Hayes MC; Mead GM
J Urol; 2009 May; 181(5):2090-6; discussion 2096. PubMed ID: 19286222
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors.
Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
J Urol; 2014 May; 191(5 Suppl):1485-90. PubMed ID: 24679874
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease.
Nicolai N; Necchi A; Raggi D; Biasoni D; Catanzaro M; Piva L; Stagni S; Maffezzini M; Torelli T; Faré E; Giannatempo P; Pizzocaro G; Colecchia M; Salvioni R
Urology; 2015 Feb; 85(2):402-6. PubMed ID: 25623702
[TBL] [Abstract][Full Text] [Related]
7. Giant mixed Sertoli-Leydig-Granulosa sex cord tumor of the testis; clinical, histopathological, and radiological features: a case report.
Tahaineh S; Mughli RA; Fallatah M
Pan Afr Med J; 2017; 27():51. PubMed ID: 28819473
[TBL] [Abstract][Full Text] [Related]
8. Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
Mosharafa AA; Foster RS; Bihrle R; Koch MO; Ulbright TM; Einhorn LH; Donohue JP
Cancer; 2003 Aug; 98(4):753-7. PubMed ID: 12910519
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Care and Survival Outcomes for Malignant Sex Cord Stromal Testicular Cancer: Results from the National Cancer Data Base.
Banerji JS; Odem-Davis K; Wolff EM; Nichols CR; Porter CR
J Urol; 2016 Oct; 196(4):1117-22. PubMed ID: 27036305
[TBL] [Abstract][Full Text] [Related]
10. Testicular sex cord-stromal tumours: the Edinburgh experience 1988-2002, and a review of the literature.
Conkey DS; Howard GC; Grigor KM; McLaren DB; Kerr GR
Clin Oncol (R Coll Radiol); 2005 Aug; 17(5):322-7. PubMed ID: 16097561
[TBL] [Abstract][Full Text] [Related]
11. Analysis of clinical-pathologic variables, staging and prognostic groups, and therapeutic results of 106 germ-cell testicular tumors.
Bonet AS; Muñoz-Delgado EG; Vico FJ; Ruiz JC; Chapado MS
Arch Esp Urol; 2011 Dec; 64(10):972-80. PubMed ID: 22228895
[TBL] [Abstract][Full Text] [Related]
12. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905
[TBL] [Abstract][Full Text] [Related]
13. Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection.
Liu NW; Cary C; Strine AC; Beck SD; Masterson TA; Bihrle R; Foster RS
Urology; 2015 Nov; 86(5):981-4. PubMed ID: 26232690
[TBL] [Abstract][Full Text] [Related]
14. [Surveillance of stage I testicular seminoma: 20 years oncological results].
Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
[TBL] [Abstract][Full Text] [Related]
15. Primary testicular lymphoma.
Miedler JD; MacLennan GT
J Urol; 2007 Dec; 178(6):2645. PubMed ID: 17945289
[No Abstract] [Full Text] [Related]
16. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Patients With Sertoli and Leydig Cell Testis Neoplasms From a National Population-Based Registry.
Osbun N; Winters B; Holt SK; Schade GR; Lin DW; Wright JL
Clin Genitourin Cancer; 2017 Apr; 15(2):e263-e266. PubMed ID: 27594555
[TBL] [Abstract][Full Text] [Related]
19. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
[TBL] [Abstract][Full Text] [Related]
20. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
